Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 23, Issue 7, Pages 2298-2308Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.23.7.2298-2308.2003
Keywords
-
Categories
Funding
- NCI NIH HHS [CA18587] Funding Source: Medline
- NIAID NIH HHS [AI42246] Funding Source: Medline
- NIDDK NIH HHS [R01 DK037871, DK37871] Funding Source: Medline
- NIGMS NIH HHS [R01 GM068820] Funding Source: Medline
Ask authors/readers for more resources
Lad is an SH2 domain-containing adaptor protein that binds MEK kinase 2 (MEKK2), a mitogen-activated protein kinase (MAPK) kinase kinase for the extracellular signal-regulated kinase 5 (ERK5) and JNK pathways. Lad and MEKK2 are in a complex in resting cells. Antisense knockdown of Lad expression and targeted gene disruption of MEKK2 expression results in loss of epidermal growth factor (EGF) and stress stimuli-induced activation of ERK5. Activation of MEKK2 and the ERK5 pathway by EGF and stress stimuli is dependent on Src kinase activity. The Lad-binding motif is encoded within amino acids 228 to 282 in the N terminus of MEKK2, and expression of this motif blocks Lad-MEKK2 interaction, resulting in inhibition of Src-dependent activation of MEKK2 and ERK5. JNK activation by EGF is similarly inhibited by loss of Lad or MEKK2 expression and by blocking the interaction of MEKK2 and Lad. Our studies demonstrate that Src kinase activity is required for ERK5 activation in response to EGF, MEKK2 expression is required for ERK5 activation by Src, Lad and MEKK2 association is required for Src activation of ERK5, and EGF and Src stimulation of ERK5-regulated MEF2-dependent promoter activity requires a functional Lad-MEKK2 signaling complex.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available